Relmada Therapeutics Inc
NASDAQ:RLMD
Relmada Therapeutics Inc
NASDAQ:RLMD
Price:
7.18
USD
-0.14%
Market Cap:
$753.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
S
|
Shenzhen Kaifa Technology Co Ltd
SZSE:000021
|
CN |
|
Katoro Gold PLC
LSE:KAT
|
UK |
|
C
|
Crest Resources Inc
CNSX:CRES
|
CA |
|
ACI Worldwide Inc
NASDAQ:ACIW
|
US |
|
Ostin Technology Group Co Ltd
NASDAQ:OST
|
CN |
|
3i Group PLC
LSE:III
|
UK |
|
SORIL Infra Resources Ltd
NSE:SORILINFRA
|
IN |
|
P
|
ProKidney Corp
NASDAQ:PROK
|
US |
|
Gear4music (Holdings) PLC
F:G4A
|
UK |
|
Tianneng Battery Group Co Ltd
SSE:688819
|
CN |
|
Japan Exchange Group Inc
TSE:8697
|
JP |
|
Decipher Labs Ltd
BSE:524752
|
IN |
|
P
|
Pavilion Real Estate Investment Trust
KLSE:PAVREIT
|
MY |
|
OUTsurance Group Ltd
OTC:RMRHF
|
ZA |
|
Orchid Island Capital Inc
NYSE:ORC
|
US |
|
Dustin Group AB
STO:DUST
|
SE |
|
MPS Infotecnics Ltd
NSE:VISESHINFO
|
IN |
|
N
|
Neptune Co
KOSDAQ:217270
|
KR |
|
MNP Petroleum Corp
OTC:MNAP
|
CH |
|
Inspira Technologies Oxy BHN Ltd
NASDAQ:IINN
|
IL |
|
Samsung Electronics Co Ltd
LSE:SMSD
|
KR |
|
P
|
Plenitude Bhd
KLSE:PLENITU
|
MY |
|
Manulife Financial Corp
TSX:MFC
|
CA |
Balance Sheet
Balance Sheet Decomposition
Relmada Therapeutics Inc
Relmada Therapeutics Inc
Balance Sheet Decomposition is not available for
Relmada Therapeutics Inc
Relmada Therapeutics Inc
Balance Sheet
Relmada Therapeutics Inc
Relmada Therapeutics Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
36
|
3
|
44
|
5
|
4
|
4
|
3
|
|
| Cash Equivalents |
36
|
3
|
44
|
5
|
4
|
4
|
3
|
|
| Short-Term Investments |
80
|
115
|
168
|
143
|
92
|
41
|
90
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
11
|
4
|
1
|
1
|
1
|
|
| Total Current Assets |
117
|
118
|
223
|
153
|
98
|
46
|
94
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
117
N/A
|
118
+1%
|
223
+89%
|
153
-32%
|
98
-36%
|
46
-53%
|
94
+105%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
8
|
11
|
5
|
4
|
4
|
2
|
|
| Accrued Liabilities |
1
|
4
|
4
|
7
|
9
|
6
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
13
|
15
|
13
|
12
|
10
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Liabilities |
2
N/A
|
13
+740%
|
15
+20%
|
13
-17%
|
12
-2%
|
10
-16%
|
7
-27%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
120
|
179
|
305
|
462
|
561
|
641
|
698
|
|
| Additional Paid In Capital |
236
|
285
|
513
|
603
|
646
|
676
|
785
|
|
| Total Equity |
116
N/A
|
106
-9%
|
208
+97%
|
140
-33%
|
85
-39%
|
36
-58%
|
87
+144%
|
|
| Total Liabilities & Equity |
117
N/A
|
118
+1%
|
223
+89%
|
153
-32%
|
98
-36%
|
46
-53%
|
94
+105%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
15
|
16
|
28
|
30
|
30
|
30
|
73
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
